☆Camber Capital Management LP
Quality Q
0.470
AUM ($M)
718
Positions
23
Turnover
0.27
Top-10 wt
79%
Herfindahl
0.076
History (qtrs)
2
Excess Return
+7.4%
AI Eval Run AI Eval
Holdings · 32 positions · portfolio value $718M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ZBH funds › | ZIMMER BIOMET HOLDINGS INC | TRIM | — | 12.7% | -3.2% | 91.2 | 1,000,000 | -1,250,000 | 1 | — |
| ☆BAX funds › | BAXTER INTL INC | TRIM | — | 12.0% | -0.3% | 86.3 | 2,850,000 | -2,900,000 | 1 | — |
| ☆HUM funds › | HUMANA INC | TRIM | — | 10.2% | -1.8% | 73.3 | 300,000 | -425,000 | 1 | — |
| ☆CVS funds › | CVS HEALTH CORP | TRIM | — | 10.1% | +0.6% | 72.4 | 1,050,000 | -1,200,000 | 1 | — |
| ☆GMED funds › | GLOBUS MED INC | TRIM | — | 6.6% | +0.9% | 47.2 | 800,000 | -450,000 | 1 | — |
| ☆ICLR funds › | ICON PLC | NEW | — | 6.1% | +6.1% | 43.6 | 300,000 | +300,000 | 1 | -6.5% |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA A/S | TRIM | — | 6.0% | +2.6% | 43.1 | 250,000 | -100,000 | 1 | — |
| ☆MRK funds › | MERCK & CO INC | NEW | — | 5.5% | +5.5% | 39.6 | 500,000 | +500,000 | 1 | +39.5% |
| ☆PFE funds › | PFIZER INC | TRIM | — | 5.1% | +1.1% | 36.4 | 1,500,000 | -1,000,000 | 1 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | ADD | — | 4.6% | +2.4% | 33.0 | 600,000 | +100,000 | 1 | — |
| ☆UNH funds › | UNITEDHEALTH GROUP INC | NEW | — | 4.3% | +4.3% | 31.2 | 100,000 | +100,000 | 1 | +7.4% |
| ☆VTRS funds › | VIATRIS INC | TRIM | — | 3.4% | -0.7% | 24.6 | 2,750,000 | -4,750,000 | 1 | — |
| ☆BKD funds › | BROOKDALE SR LIVING INC | TRIM | — | 2.1% | -0.4% | 15.0 | 2,150,000 | -4,100,000 | 1 | — |
| ☆CUSIP:98888T107 funds › | ZIMVIE INC | TRIM | — | 2.1% | +0.8% | 15.0 | 1,600,000 | -285,000 | 1 | — |
| ☆CUSIP:03753U106 funds › | APELLIS PHARMACEUTICALS INC | NEW | — | 2.0% | +2.0% | 14.7 | 850,000 | +850,000 | 1 | — |
| ☆MYGN funds › | MYRIAD GENETICS INC | TRIM | — | 1.5% | +0.2% | 10.6 | 2,000,000 | -350,000 | 1 | — |
| ☆EVH funds › | EVOLENT HEALTH INC | TRIM | — | 1.3% | -0.4% | 9.6 | 850,000 | -2,150,000 | 1 | — |
| ☆CON funds › | CONCENTRA GROUP HOLDINGS PAR | TRIM | — | 1.1% | -1.0% | 8.2 | 400,000 | -1,200,000 | 1 | — |
| ☆INGN funds › | INOGEN INC | HOLD | — | 1.0% | +0.5% | 6.9 | 975,000 | +0 | 1 | — |
| ☆DNLI funds › | DENALI THERAPEUTICS INC | TRIM | — | 0.8% | -0.3% | 5.6 | 400,000 | -850,000 | 1 | — |
| ☆TBPH funds › | THERAVANCE BIOPHARMA INC | TRIM | — | 0.7% | +0.1% | 5.0 | 450,000 | -550,000 | 1 | — |
| ☆ANAB funds › | ANAPTYSBIO INC | TRIM | — | 0.4% | -0.5% | 2.8 | 125,000 | -625,000 | 1 | — |
| ☆OSUR funds › | ORASURE TECHNOLOGIES INC | HOLD | — | 0.4% | +0.2% | 2.7 | 900,000 | +0 | 1 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | EXIT | — | 0.0% | -1.1% | 0.0 | 0 | -441,000 | 0 | — |
| ☆IONS funds › | IONIS PHARMACEUTICALS INC | EXIT | — | 0.0% | -1.4% | 0.0 | 0 | -725,000 | 0 | — |
| ☆CUSIP:N72482206 funds › | QIAGEN NV | EXIT | — | 0.0% | -3.5% | 0.0 | 0 | -1,400,000 | 0 | — |
| ☆CI funds › | THE CIGNA GROUP | EXIT | — | 0.0% | -4.1% | 0.0 | 0 | -200,000 | 0 | — |
| ☆PTCT funds › | PTC THERAPEUTICS INC | EXIT | — | 0.0% | -4.8% | 0.0 | 0 | -1,500,000 | 0 | — |
| ☆SRPT funds › | SAREPTA THERAPEUTICS INC | EXIT | — | 0.0% | -3.2% | 0.0 | 0 | -800,000 | 0 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -300,000 | 0 | — |
| ☆GMAB funds › | GENMAB A/S | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -50,000 | 0 | — |
| ☆TXG funds › | 10X GENOMICS INC | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -1,000,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2025Q2 | 718 | 23 | 0.27 | 79% | 0.076 | 0.485 | — | entered |
| 2025Q1 | 1,603 | 28 | 0.00 | 76% | 0.080 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status